Has Preston Smith, MD received payments from drug or device companies?

Yes. Drug and device makers reported $18,470 in general payments to Preston Smith, MD across 239 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Preston Smith, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Preston Smith, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Preston Smith, MD

Vascular & Interventional Radiology · Austin, TXNPI 1538444674

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (48.8%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 46 manufacturers reported payments, led by Guerbet LLC at 29.4% of the total. Reporting peaked in 2024 at $9,194 and has fallen 86.9% since, to $1,209 in 2025.

$18,470in general payments, 2019–2025

Across 239 payments — averaging $77.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Guerbet LLC$5K
Siemens Medical Solutions USA, Inc.$3K
Sirtex Medical Inc$2K
Boston Scientific$2K
Cook Medical LLC$1K
Stryker$1K
plus $5K from 40 others

What the payments were for

Consulting fees$3,00016%
Travel & lodging$6,44535%
Food & beverage$9,01049%
Gifts$150%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Guerbet LLC	6	$5,424
Siemens Medical Solutions USA, Inc.	10	$2,778
Sirtex Medical Inc	17	$1,814
Boston Scientific	61	$1,646
Cook Medical LLC	34	$1,263
Stryker	8	$1,027
Terumo Medical Corporation	6	$356
Genesys Orthopedics Systems, L.L.C.	3	$273
Penumbra, Inc.	2	$261
Medtronic(2 entities)	6	$250
Procept Biorobotics Corporation	5	$237
Philips North America LLC	5	$226
Argon Medical Devices, Inc.	2	$214
Inari Medical, Inc.	2	$202
Angiodynamics, Inc.	3	$191
Agiliti Surgical, Inc.	2	$180
Abbott	5	$175
Teleflex LLC	3	$174
Shockwave Medical, Inc	6	$150
180 Medical, Inc.	2	$143
Davol Inc.	1	$136
Ipsen Biopharmaceuticals, Inc	1	$124
Heartflow, Inc.	1	$116
KCI USA, Inc.	1	$111
Olympus America Inc.	4	$111
Antares Pharma, Inc.	5	$104
Axonics, Inc.	1	$97
Johnson & Johnson	5	$92
Cardiovascular Systems Inc.	4	$81
Endo Pharmaceuticals Inc.	5	$79
Tolmar, Inc.	3	$54
Endo USA, Inc.	2	$49
Covidien LP	3	$46
W. L. Gore & Associates, Inc.	2	$45
Novo Nordisk	2	$44
EKOS Corporation	1	$33
Halozyme Inc	1	$24
Bluewind Medical	1	$22
Laborie Medical Technologies Corp.	1	$20
Sumitomo Pharma America, Inc.	1	$18
Coloplast	1	$17
Nevro Corp.	1	$17
Ferring Pharmaceuticals Inc.	1	$16
Cardinal Health 200 LLC	1	$13
Tactile Systems Technology Inc	1	$12
Reflow Medical Inc	1	$5

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Lipiodol$5,163
SIR-Spheres Microspheres$1,445
IVS - VERTEBRAL AUGMENTATION PRODUCTS$905
Cook Medical Peripheral Intervention$380
Indigo System$261
Azur CX Detachable$249
GENERAL VASCULAR INTERVENTION$226
Cook Medical Zilver PTX$214
SACROILIAC JOINT FUSION SYSTEM$200
FlowTriever$190
ClotTriever$190
LAVA LES (Liquid Embolic System)$174
UroLift$144
Nanoknife$140
PHASIX$136
PROCLAIM$132
ONIVYDE$124
DIREXION$123
AquaBeam Robotic System$122
EMBOZENE$121

How this compares

$18,470 in reported general payments places this provider in the 80th percentile of 299 vascular & interventional radiology providers in Texas.

See all vascular & interventional radiology providers in Texas →

Medicare billing

Part B allowed, 2024

$1,004,800

Medicare patients

140

Services billed

12,018

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Methylprednisolone	95	$509
Ciprofloxacin Hcl	98	$314
Ibuprofen	96	$204
Tamsulosin Hcl	20	$185
Diazepam	64	$86

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Austin

Michael JaimesAustin$93K
Orlando DiazHouston$611K
Rahul ShethHouston$410K
Miguel MonteroHouston$386K
Joshua KubanHouston$301K
Peiman HabibollahiHouston$254K
Ahmed Abdel AalHouston$147K
Varshana GurusamyHouston$141K
Sanjeeva KalvaDallas$128K
Mehrzad ZarghouniBellaire$127K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →